https://youtu.be/QlPNRaXj2OQ

From Executive Producers Danny Glover, John Legend, BRAD PITT & Russell Simmon. This film won the Grand Jury Prize at Sundance 2012 for Documentary. http://www.thehouseilivein.org/ “2012′s BEST DOCUMENTARY! THE MOST IMPORTANT DRUG WAR FILM YOU’LL EVER SEE.” – Mark Hughes, Forbes /// As America remains embroiled in conflict overseas, a less visible war is taking place at home, costing countless lives, destroying families, and inflicting untold damage on future generations of Americans. Over forty years, the War on Drugs has accounted for more than 45 million arrests, made America the world’s largest jailer, and damaged poor communities at home and abroad. Yet for all that, drugs are cheaper, purer, and more available today than ever before. Filmed in more than twenty states, The House I Live In captures heart-wrenching stories from individuals at all levels of America’s War on Drugs. From the dealer to the grieving mother, the narcotics officer to the senator, the inmate to the federal judge, the film offers a penetrating look inside America’s longest war, offering a definitive portrait and revealing its profound human rights implications. While recognizing the seriousness of drug abuse as a matter of public health, the film investigates the tragic errors and shortcomings that have meant it is more often treated as a matter for law enforcement, creating a vast machine that feeds largely on America’s poor, and especially on minority communities. Beyond simple misguided policy, The House I Live In examines how political and economic corruption have fueled the war for forty years, despite persistent evidence of its moral, economic, and practical failures. **FAIR USE NOTICE** These Videos May Contain Copyrighted (© ) Material. The Use of Which Has Not Always Been Specifically Authorized by The Copyright Owner. Such Material is Made Available to Advance Understanding of Ecological, Political, Human Rights, Economic, Democracy, Scientific, Moral, Ethical, Social Justice Issues, Teaching, and Research. It is believed that this Constitutes a ”Fair Use” of Any Such Copyrighted Material as Provided For in Section 107 of the US Copyright Law. In Accordance With Title – 17 U.S.C. Section 107, This Material is Distributed Without PROFIT to Those Who Have Expressed a Prior General Interest in Receiving Similar Information For Research and Educational Purposes. For More Information: http://www.law.cornell.edu/uscode /// – Directed by Eugene Jarecki – Produced by Eugene Jarecki & Melinda Shopsin – Written by Eugene Jarecki – Starring Nannie Jeter & David Simon – Music by Robert Miller – Cinematography: Sam Cullman & Derek Hallquist – Release dates: October 5, 2012 – Running time: 108 minutes – Country: United States – Language: English

Filed under: General Problems | Leave a Comment »

Filed under: General Problems | 1 Comment »

Elizabeth Warren Advocates to Formalize Barriers for Pain Patients

https://filtermag.org/elizabeth-warren-partial-refills/

Five lawmakers, including Senator Elizabeth Warren, have renewed their demands for the DEA to double down on its policy of limiting pain patients’ access to their medication

 Their position is premised on a misunderstanding of the ever-worsening overdose crisis—which is currently driven by an illicit heroin and stimulant supply adulterated by the synthetic opioid, fentanyl.

In an October 6 letter to acting DEA Administrator Timothy Shea that is almost exactly the same as one from July 2018, Sen. Warren, who has a track record of supporting harm reduction services, called on the drug-war agency to update the agency’s medication “partial fill” regulation to clarify that pharmacists can voluntarily withhold some of an opioid prescription, as advised by the patient’s prescriber. Patients can also request them.

The bipartisan Comprehensive Addiction and Recovery Act (CARA) of 2016 authorized these partial fills of Schedule II controlled substances when pharmacists are “unable to supply the full quantity.” This was an attempt, the bill states, to “address the prescription opioid abuse and heroin use crisis” by cutting patients’ access to medications. But due to the DEA’s “foot dragging,” as the five politicians describe it, part of the legislation remains unimplemented

“We can’t afford to neglect the opioid epidemic, nor the communities it is affecting the most, while we continue to combat COVID-19,” wrote Senator Warren in an op-ed published by a local Massachusetts newspaper less than a week before her latest letter to the DEA.

But her advocacy in the name of people who use opioids may have mixed results for their wellbeing. Warren’s press team did not respond to Filter‘s request for comment.

Opioid analgesics can be crucial for pain patients’ mental and physical wellbeing, and partial fills may function as a type of harm reduction support. “If someone’s having trouble controlling their medication, it’s a good thing,” pain patient advocate Anne Fuqua told Filter. The current accepted use of partial fills for when pharmacists run out of a medication is also beneficial to patients, she added. “If my pharmacy is out, I’d have to wait or forfeit [my prescription]. You’d have to get a second prescription and some doctors don’t care.”

On the flip side, for Fuqua, partial fills could make pain patients’ lives more difficult. “If the doctor writes a script for once a month but you have to pick it up every week, that would be a tremendous burden.”

They therefore risk adding one more barrier for patients who have already been harmed by other prohibitionist attempts at getting a handle on the overdose crisis. “Clinicians might universally stop prescribing opioids, even in situations in which the benefits might outweigh their risks,” the Centers for Disease Control and Prevention (CDC) wrote in a 2017 commentary. “Such actions disregard messages emphasized in the guideline that clinicians should not dismiss patients from care, which can adversely affect patient safety, could represent patient abandonment, and can result in missed opportunities to provide potentially lifesaving information and treatment.”

Politicians’ fixation on the prescription opioid supply further misses what is driving record-breaking, preventable overdose deaths—especially among poor communities and communities of color, both of whom have been made vulnerable to drug-related harms by the federal governments’ austere health policy.

Deaths involving cocaine and methamphetamine reportedly surpassed those of most opioids for the first-time in August 2019, an apparent turning point in the nature of the drug-involved deaths crisis in the United States. The latest CDC data show that, in the last month of that summer, more people’s predicted deaths involved cocaine (15,206) and/or “psychostimulants with abuse potential” (15,180)—a vague category that includes crystal meth—than those involving heroin (14,674), “natural & semi-synthetic opioids” (12,093), meaning opioid analgesics, and/or methadone (2,849) combined.

Black Americans who use cocaine are disproportionately likely to die from an overdose or overamp. According to a September 2020 study, 11 percent of reported cocaine users are non-Hispanic Black, yet more than one-quarter (27 percent) of cocaine-related fatalities involved non-Hispanic Black people. In 2018, the non-Hispanic Black cocaine-involved death rate was twice that of whites, despite past-year cocaine use prevalence being about the same between the two groups.

The synthetic opioid fentanyl is playing a large part in the current overdose crisis too. As of February 2020, it was by far the most common substance involved in the historic death toll. But its supply is mostly through illicit markets, not patient diversion, as the DEA has reported.

Warren’s recent op-ed failed to recognize these trends. Instead, she continued to characterize the issue as an “opioid crisis” and made no mention of the role of stimulants. She did mention fentanyl, but only to say that pharmaceutical companies left people who use drugs “vulnerable to developing addictions to more dangerous and illicit substances like fentanyl.” While some people have come to prefer fentanyl (which doesn’t necessarily indicate addiction), many who experience its harms don’t know about its presence in their drugs.

Warren has worked to advance laws that hold greater promise for ending the crisis. In April 2018, she and the late Representative Elijah Cummings introduced the Comprehensive Addiction Resources Emergency (CARE) Act—a bill, yet to become law, that would provide to frontline interventions what CARA failed to: money. Billions in federal funds would go to bolstering hard-hit jurisdictions’ responses; advancing public health research and surveillance; supporting treatment, prevention, recovery and harm reduction; and expanding professional and public access to naloxone, the opioid overdose reversal medication.

Filed under: General Problems | 2 Comments »

Are these FIVE LEGISLATORS proposing a bill that would cause the DEA and other agencies/entities to discriminate against all pain pts – including those with intractable chronic pain  – that would be a civil rights violation of both the American with Disability Act & Civil Rights Act ?  Does this make this proposed bill UNCONSTITUTIONAL before it even gets a vote to pass ?

Elizabeth Warren Advocates to Formalize Barriers for Pain Patients

https://filtermag.org/elizabeth-warren-partial-refills/

Five lawmakers, including Senator Elizabeth Warren, have renewed their demands for the DEA to double down on its policy of limiting pain patients’ access to their medication. Their position is premised on a misunderstanding of the ever-worsening overdose crisis—which is currently driven by an illicit heroin and stimulant supply adulterated by the synthetic opioid, fentanyl.

In an October 6 letter to acting DEA Administrator Timothy Shea that is almost exactly the same as one from July 2018, Sen. Warren, who has a track record of supporting harm reduction services, called on the drug-war agency to update the agency’s medication “partial fill” regulation to clarify that pharmacists can voluntarily withhold some of an opioid prescription, as advised by the patient’s prescriber. Patients can also request them.

The bipartisan Comprehensive Addiction and Recovery Act (CARA) of 2016 authorized these partial fills of Schedule II controlled substances when pharmacists are “unable to supply the full quantity.” This was an attempt, the bill states, to “address the prescription opioid abuse and heroin use crisis” by cutting patients’ access to medications. But due to the DEA’s “foot dragging,” as the five politicians describe it, part of the legislation remains unimplemented

“We can’t afford to neglect the opioid epidemic, nor the communities it is affecting the most, while we continue to combat COVID-19,” wrote Senator Warren in an op-ed published by a local Massachusetts newspaper less than a week before her latest letter to the DEA.

But her advocacy in the name of people who use opioids may have mixed results for their wellbeing. Warren’s press team did not respond to Filter‘s request for comment.

Opioid analgesics can be crucial for pain patients’ mental and physical wellbeing, and partial fills may function as a type of harm reduction support. “If someone’s having trouble controlling their medication, it’s a good thing,” pain patient advocate Anne Fuqua told Filter. The current accepted use of partial fills for when pharmacists run out of a medication is also beneficial to patients, she added. “If my pharmacy is out, I’d have to wait or forfeit [my prescription]. You’d have to get a second prescription and some doctors don’t care.”

On the flip side, for Fuqua, partial fills could make pain patients’ lives more difficult. “If the doctor writes a script for once a month but you have to pick it up every week, that would be a tremendous burden.”

They therefore risk adding one more barrier for patients who have already been harmed by other prohibitionist attempts at getting a handle on the overdose crisis. “Clinicians might universally stop prescribing opioids, even in situations in which the benefits might outweigh their risks,” the Centers for Disease Control and Prevention (CDC) wrote in a 2017 commentary. “Such actions disregard messages emphasized in the guideline that clinicians should not dismiss patients from care, which can adversely affect patient safety, could represent patient abandonment, and can result in missed opportunities to provide potentially lifesaving information and treatment.”

Politicians’ fixation on the prescription opioid supply further misses what is driving record-breaking, preventable overdose deaths—especially among poor communities and communities of color, both of whom have been made vulnerable to drug-related harms by the federal governments’ austere health policy.

Deaths involving cocaine and methamphetamine reportedly surpassed those of most opioids for the first-time in August 2019, an apparent turning point in the nature of the drug-involved deaths crisis in the United States. The latest CDC data show that, in the last month of that summer, more people’s predicted deaths involved cocaine (15,206) and/or “psychostimulants with abuse potential” (15,180)—a vague category that includes crystal meth—than those involving heroin (14,674), “natural & semi-synthetic opioids” (12,093), meaning opioid analgesics, and/or methadone (2,849) combined.

Black Americans who use cocaine are disproportionately likely to die from an overdose or overamp. According to a September 2020 study, 11 percent of reported cocaine users are non-Hispanic Black, yet more than one-quarter (27 percent) of cocaine-related fatalities involved non-Hispanic Black people. In 2018, the non-Hispanic Black cocaine-involved death rate was twice that of whites, despite past-year cocaine use prevalence being about the same between the two groups.

The synthetic opioid fentanyl is playing a large part in the current overdose crisis too. As of February 2020, it was by far the most common substance involved in the historic death toll. But its supply is mostly through illicit markets, not patient diversion, as the DEA has reported.

Warren’s recent op-ed failed to recognize these trends. Instead, she continued to characterize the issue as an “opioid crisis” and made no mention of the role of stimulants. She did mention fentanyl, but only to say that pharmaceutical companies left people who use drugs “vulnerable to developing addictions to more dangerous and illicit substances like fentanyl.” While some people have come to prefer fentanyl (which doesn’t necessarily indicate addiction), many who experience its harms don’t know about its presence in their drugs.

Warren has worked to advance laws that hold greater promise for ending the crisis. In April 2018, she and the late Representative Elijah Cummings introduced the Comprehensive Addiction Resources Emergency (CARE) Act—a bill, yet to become law, that would provide to frontline interventions what CARA failed to: money. Billions in federal funds would go to bolstering hard-hit jurisdictions’ responses; advancing public health research and surveillance; supporting treatment, prevention, recovery and harm reduction; and expanding professional and public access to naloxone, the opioid overdose reversal medication.

Filed under: General Problems | 3 Comments »

NBC News reached out to all 50 state pharmacy boards, which oversee mail-order pharmacies, and the vast majority don’t have specific rules about how to ship medication, saying it’s up to the pharmacy to ensure it’s done safely.

There is a publication called  https://www.usp.org/ United States Pharmacopeia     that has been around for abt 200 yrs and within it is described the storage requirements for all medications, including most all OTC meds…  all Rx meds will have a exact F/C range and OTC may just state “store at room temperature”.  The Pharma, drug wholesaler, Pharmacy are legally required to meet those storage temps while the medications are in their possession.   Once the pharmacy hands a package containing medications – to a delivery service (USPS, USP, FedEx)… the legal obligation to maintain those storage temperature requirements – basically “flies out the window”..

The representative of Express Scripts – Wendy Barnes –  the President of HOME DELIVERY for Express Scripts… I will presume that she is not a Pharmacist…. so Express Scripts is putting forth a person who according to her LinkedIN page has a BS in Biochemistry and a MBA.  https://www.linkedin.com/in/wendy-barnes-6bb15639/  So saving ONE DOLLAR on the not using temp sensor in the shipping package. I just wonder how much Sophia Dean’s insurance company had to pay out for the feeding tube and tube feedings and hospitalization costs… because Express Scripts was more concern about “pinching pennies” that favored their bottom line.

The fact that they got an exception to fill Sophia’s medication at the local pharmacy – notice that they use a INDEPENDENT PHARMACY – suggests that those other costs to the insurance company for hospitalization and related tube feeding costs WERE SUBSTANTIAL.

It does not surprise me that the board of Pharmacy shirk their study and their primary charge of protecting public safety in regards medications.  I suspect that since there was nothing involving the potential of diversion of controlled substances… it is not the board of Pharmacy’s concern.

What was not addressed in the article is that Express Scripts is/was primarily a PBM ( Prescription Benefit Manager) whose primary function is to process Rx claims from community pharmacies on behalf of a insurance company, but apparently they have taken advantage of their position to expand their business plan into the mail order prescription business…. and went to the insurance company and told them they could cut a certain percent of medication cost if they could “force” their employees to use Express Scripts’ mail order facility…   What the employer didn’t understand that these PBM’s typically keep the lion’s share of what is saved by Express Scripts mail order pharmacy … goes into Express Scripts’ bottom line.

Here is just ONE OF MANY such lawsuits  https://www.washingtonpost.com/news/wonk/wp/2016/03/21/anthem-sues-express-scripts-over-prescription-drug-pricing/  and this law suit was not over just “pennies”   Anthem seeks $15 billion in damages for uncompetitive pharmacy pricing from Dec. 1, 2015 through 2020. I used this “express scripts sued by insurance company over rebates” for a web search and got PAGES of responses of many entities suing Express Scripts over them pocketing money that they were suppose to pay the entity they had a contract with.

Filed under: General Problems | Leave a Comment »

The steady stream of celebrity stories about prescription drug abuse makes Americans keenly aware of the dangers of overdosing on medications like OxyContin and Vicodin. And from President Obama’s Drug Czar to California Attorney General Jerry Brown, politicians are calling for greater power to monitor doctor-patient relationships in order to fight the “epidemic” of prescription drug overdosing.

But maybe the real epidemic is underdosing. Countless Americans suffer with severe chronic pain because doctors are afraid to treat them properly.

Michael Jackson’s death unleashed a flurry of media stories about all aspects of the pop star’s life, including his alleged prescription drug abuse. On the same day countless millions watched Jackson’s star-studded memorial service, reason.tv interviewed another musician.

Seán Clarke-Redmond, a man who enjoyed an active live before the neurodegenerative disease ALS, often referred to as Lou Gerig’s disease, rendered him nearly immobile—he can no longer even play the piano.

The disease also left him in almost constant pain. Redmond is prescribed some medication, but not nearly enough to keep his pain under control. Dr. Frank Fisher says Redmond’s case is an appallingly common one.

“Chronic pain in America is an enormously under treated disease,” says Fisher, a Harvard-trained physician. “It’s a public health disaster.”

Pain specialists like Fisher and patients’ groups like the Pain Relief Network battle law enforcement officials who are forever on the lookout for “pill mills” and patients who misuse pain medicine. Fisher notes that the same medications so often associated with celebrity addiction are the same medications that combat pain most effectively.

Fisher has treated his patients with high doses of opioids-that is, until a swat team raided his clinic and threw him behind bars.

“They were trying to give me 256 years to life,” says Fisher who argues that fear of prosecution often prevents doctors from treating chronic pain patients effectively.

What allows doctors’ medical decisions to be overruled by police?

“What we’re dealing with is a mass insanity,” says Fisher. “We call it the war on drugs.”

“When Cops Play Doctor” is written and produced by Ted Balaker and hosted by Nick Gillespie. Director of Photography is Alex Manning, Associate Producers are Hawk Jensen and Paul Detrick.

Filed under: General Problems | 5 Comments »

Michigan rep Cynthia A Johnson making threats against Trump Supporters 12-8 MI

BUT don’t worry … she has been PUNISHED…. she lost all her committee assignments thru 12/31/2020

according to the Congressional calendar  https://www.nab.org/documents/advocacy/2020CongressionalCalendar.pdf   … the House leaves for Christmas break on Thursday Dec 10,2020 — which is TOMORROW !!

Filed under: General Problems | 1 Comment »

COVID-19: Allergic Reaction Warning for Pfizer/BioNTech Vaccine

https://www.medscape.com/viewarticle/942285

UK regulators have issued a warning that people who have a history of significant allergic reactions should not currently receive the Pfizer/BioNTech vaccine.

The incidents relate to two healthcare workers who suffered allergic reactions after having the vaccine yesterday but who have since recovered.

MHRA Chief Executive Dr June Raine told MPs on the Commons Health and Science Committee: “Last evening, we were looking at two case reports of allergic reactions. We know from the very extensive clinical trials that this wasn’t a feature. But if we need to strengthen our advice now that we’ve had this experience in the vulnerable populations, the groups who’ve been selected as a priority, we get that advice to the field immediately.”

Pfizer UK said in a statement: “We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the COVID-19 BNT162b2 vaccine.

“As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.

“In the pivotal phase 3 clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee. The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination.”

Trial Data

Data released by the US FDA show a small number of allergic reactions reported in both the vaccine and placebo trial groups (0.63% and 0.51%).

Commenting via the Science Media Centre, Professor Peter Openshaw, past-president of the British Society for Immunology, Imperial College London, said: “The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that this monitoring system is working well.”

Dr Raine also told MPs “data packages for the AstraZeneca/Oxford vaccine have been arriving”. She didn’t commit to a date for a decision but said “work is proceeding intensively, and with great scientific rigour”.

She was asked about the half dose, full dose approach that gave better results than two full doses. “Clearly we have a great interest into the possible reasons for the different doses having a different efficacy effectiveness readout. But the position is we will look at every piece of evidence.”

She added: “We will be reaching a position on the basis of all completed studies and analyses. And of course, part of that will be to examine with great rigour the basis for the appropriate dosage regimen for UK people.”

Filed under: General Problems | Leave a Comment »

COVID-19 Vaccine Has Potential Side Effects, Nurse Volunteer Says

https://www.medscape.com/viewarticle/942133

Nurse researcher Kristen Choi, PhD, RN, experienced first-hand a “worst-case scenario” of potential side effects after receiving an experimental COVID-19 vaccine in a phase 3 trial. She says clinicians should be prepared to reassure patients if reports of similar experiences spread when vaccine rollouts begin.

“This was the highest fever I can ever remember having, and it scared me,” said Choi, with the School of Nursing at the University of California, Los Angeles.

Choi volunteered to participate in Pfizer’s COVID-19 vaccine trial in August. When she came back for the second dose in September she began to experience distressing symptoms.

The symptoms, she writes in a perspective piece published online today in JAMA Internal Medicine, started with immediate pain at the injection site. By nightfall, she felt “felt light-headed, chilled, nauseous, and had a splitting headache” and went to bed.

She woke up at midnight and the symptoms had intensified and she could hardly move her arm from injection-site pain. Choi slept fitfully and when she woke up at 5:30 AM her thermometer read 104.9 °F (40.5 °C).

By the next morning all symptoms had disappeared except for a sore bump at the injection site.

Because the trial was blinded, Choi wasn’t told whether she received the vaccine or placebo, but the symptoms left her with little doubt.

She told Medscape Medical News her reason for writing the article was to let anyone who will be administering a COVID-19 vaccine know that when a rollout begins some patients may experience the same side effects.  Disclosure forms are not enough to make sure people understand that what they may experience is normal, she said.

After all, even Choi, who administers vaccines and whose career centers on research, began to fear something was wrong when symptoms flared even though she was thoroughly briefed on potential side effects. She says rational thought for her went out the window when her fever spiked.

Experts Say Her Symptom Combination Is Unusual

Two vaccine experts told Medscape Medical News that Choi’s symptoms were the extreme case and the vast majority of people will not experience her level of discomfort.

But they both agree Choi’s message is an important reminder that healthcare professionals need to be prepared to answer questions when the rollouts begin.

Her story may also point out the need for creating a hotline for 24/7 access so that if patients do experience severe symptoms they can get answers right away, they said.

William J. Moss, MD, MPH, executive director of the International Vaccine Access Center at Johns Hopkins’ Bloomberg School of Public Health in Baltimore, Maryland, told Medscape Medical News that spotlights on individual cases of extreme side effects should be paired with spotlights on the experience of a patient with COVID-19 in an intensive care unit to give proper context.

“The type of side effects we’re seeing with the Pfizer and Moderna vaccines are typical of any vaccine, though there is a spectrum,” Moss said.

“The numbers I’ve seen range from maybe 2% to 10% ­­— maybe up to 15% — of people having these kinds of really noticeable side effects. Again all transient. But some people have more severe [reactions] than others.” Moss continued. He notes that any inflammatory response — or reactogenicity — is normal.

“What we don’t want is for people to be surprised by that,” he said.

An important point, Moss says, is that “these are always transient, lasting 12-36 hours, maybe 48 hours.”

Moss said people getting the vaccines should leave the vaccination location knowing a phone number to call if they experience severe symptoms so that they can talk directly with a healthcare professional at any time of day or night.

“I Would Do it Again in a Heartbeat”

Choi wants to be clear that her message is not meant to warn against the vaccine itself: “I would do it again in a heartbeat even if I knew I was going to have the same reaction,” she said.

Her message, rather, is that clinicians may be underestimating the effort it will take to be ready to correct misinformation; they should reassure patients that the symptoms come because the body is training itself to fight the virus.

Albert Rizzo, MD, chief medical officer for the American Lung Association, told Medscape Medical News that the side effects Choi experienced — especially all at once — are uncommon with the Pfizer vaccine as well as with the other two frontrunners by Moderna and Oxford/AstraZeneca.

“People should not expect to get that many side effects,” he said.

However, milder side effects, such as soreness at the injection site, are common, he said.

Part of the message to patients should include the risk–benefit balance: an emphasis should be placed on weighing the deadly risk of COVID-19 as well as the benefit of helping protect society at large against potential vaccine side effects, he said.

Healthcare professionals should partner with other trusted influencers within cultures, particularly among people of color, where trust of vaccines is particularly low, Rizzo said. Leaders who understand both the hesitancy and the need for the vaccine can help reinforce the clinical message.

The American Lung Association, for instance, is partnering in the Black community with church pastors and community health center clinicians.

“We can’t just from on high say this is an important thing to do,” he said.

Choi reports grants from the Agency for Healthcare Research and Quality outside the submitted work. Rizzo and Moss have disclosed no relevant financial relationships.

Filed under: General Problems | 1 Comment »

Amazon Pharmacy Boasts Big Discounts for Prescription Meds, but Probably Isn’t the Best Deal

https://www.healthline.com/health-news/amazon-pharmacy-boasts-big-discounts-for-prescription-meds-but-probably-isnt-the-best-deal#Amazon-Pharmacy-has-potential,-but-likely-wont-be-a-game-changer-for-prescription-drug-prices

Filed under: General Problems | Leave a Comment »